Concepedia

Lijuan Zhu

LZ

9

Publications

975

Citations

9

H-Index

1997

Active since

Affiliations

Novartis (United States)(Current)

Lijuan Zhu is an author at Novartis (United States) specializing in medicine, pharmacology, and biochemistry.

ORCID

Top concepts

Publications per year

1997–2023

9

Publications

9

Reducing, Radical Scavenging, and Chelation Properties of in Vitro Digests of Alcalase-Treated Zein Hydrolysate

Lijuan Zhu, Jie Chen, Xueyan Tang et al. · Journal of Agricultural and Food Chemistry · 2008 · 355 citations

Discovery of CGS 27023A, a Non-Peptidic, Potent, and Orally Active Stromelysin Inhibitor That Blocks Cartilage Degradation in Rabbits

Lawrence MacPherson, Erol K. Bayburt, Michael Capparelli et al. · Journal of Medicinal Chemistry · 1997 · 325 citations · Full text

Identification of Dipeptidyl Nitriles as Potent and Selective Inhibitors of Cathepsin B through Structure-Based Drug Design

Paul D. Greenspan, Kirk Clark, Rubén Tommasi et al. · Journal of Medicinal Chemistry · 2001 · 136 citations · Full text

Discovery of Potent, Selective, and Orally Active Carboxylic Acid Based Inhibitors of Matrix Metalloproteinase-13

Lauren G. Monovich, Rubén Tommasi, Roger A. Fujimoto et al. · Journal of Medicinal Chemistry · 2009 · 56 citations · Full text

, , +19

A novel NAE/UAE dual inhibitor LP0040 blocks neddylation and ubiquitination leading to growth inhibition and apoptosis of cancer cells

Peng Lü, Yahui Guo, Lijuan Zhu et al. · European Journal of Medicinal Chemistry · 2018 · 30 citations

, , +8

Rows per page

1–5 of 9